ReviewJournal of clinical medicine2025

A New Direction in Endometrial Cancer Therapy-PD-1 and PD-L1 Immune Checkpoint Inhibitors-Where Will It Take Us?

Natalia Mielnicka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.